Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunocore Hldgs Q1 GAAP EPS $0.10 Beats $(0.39) Estimate, Sales $93.88M Beat $88.52M Estimate

Author: Benzinga Newsdesk | May 07, 2025 09:36am
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.39) by 125.64 percent. This is a 120.41 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $93.88 million which beat the analyst consensus estimate of $88.52 million by 6.05 percent. This is a 33.16 percent increase over sales of $70.50 million the same period last year.

Posted In: IMCR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist